In "Episode 2" of the series on "Present and future of diagnostics in prostate cancer," Prof. Monique Roobol (NL) and Dr. Tamás Fazekas (HU) review the ongoing debate surrounding prostate cancer screening.
They review the history and development of screening strategies, including the key findings from early trials and the progression toward more personalised, risk-stratified approaches.
Prof. Roobol discusses the significance of PSA testing and how it serves as a tool for initial risk stratification, while also addressing...
This video is part one of a four-part series where we review helpful screening and diagnostic tools for prostate cancer. This video highlights the basics of prostate cancer, its risk factors and how early screenings can help.
Chapters
00:07: What is prostate cancer? 01:13: What are the risk factors for prostate cancer? 01:39: Early screenings help.
* Dr. Carlsson asserts that prostate cancer screening is moving toward integrated, risk-adapted models, combining PSA, biomarkers, imaging, and AI to optimize outcomes for men globally.
Dr. Sigrid Carlsson, MD, PhD, MPH, Head, Division of Clinical Epidemiology of Early Cancer Detection, DKFZ German Cancer Research Center, Heidelberg, Germany, reviews future directions in prostate cancer screening. She emphasizes that despite available screening, men continue to die of prostate cancer, and opportunistic, non-standardized...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.